Suzhou Novoprotein Scientific Co (SHSE:688137) Beginning Cash Position: ¥772.6 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688137 Suzhou Novoprotein Scientific Co Ltd SHSE:688137
58 GF Score
Price ¥62.15
GF Value ¥39.81
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Suzhou Novoprotein Scientific Co Beginning Cash Position?

Suzhou Novoprotein Scientific Co SHSE:688137 -2.54% 58 Beginning Cash Position is ¥772.6 Mil as of Jun. 2026. GuruFocus rates SHSE:688137 with a GF Score™ of 58/100 and a GF Value™ of ¥39.81 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Suzhou Novoprotein Scientific Co's Beginning Cash Position for the quarter that ended in Jun. 2026 was ¥772.6 Mil.

Suzhou Novoprotein Scientific Co's quarterly Beginning Cash Position declined from Dec. 2025 (¥798.8 Mil) to Mar. 2026 (¥710.8 Mil) but then increased from Mar. 2026 (¥710.8 Mil) to Jun. 2026 (¥772.6 Mil).

Suzhou Novoprotein Scientific Co's annual Beginning Cash Position declined from Dec. 2023 (¥929.3 Mil) to Dec. 2024 (¥863.7 Mil) and declined from Dec. 2024 (¥863.7 Mil) to Dec. 2025 (¥647.0 Mil).

Suzhou Novoprotein Scientific Co Beginning Cash Position Related Terms

Suzhou Novoprotein Scientific Co Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Suzhou Novoprotein Scientific Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Novoprotein Scientific Co Beginning Cash Position Chart

Suzhou Novoprotein Scientific Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 68.64 189.39 929.33 863.68 646.99

Suzhou Novoprotein Scientific Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 687.35 773.47 798.84 710.81 772.59
SHSE:688137
58GF Score
Suzhou Novoprotein Scientific Co Ltd SHSE:688137
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzhou Novoprotein Scientific Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of ¥772.6 Mil mean?
Suzhou Novoprotein Scientific Co (SHSE:688137) has a Beginning Cash Position of ¥772.6 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Suzhou Novoprotein Scientific Co and its competitors.
Is Suzhou Novoprotein Scientific Co's Beginning Cash Position too high?
Suzhou Novoprotein Scientific Co's current Beginning Cash Position is ¥772.6 Mil. Overall, Suzhou Novoprotein Scientific Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Suzhou Novoprotein Scientific Co's Beginning Cash Position compare to VRTX and REGN?
Suzhou Novoprotein Scientific Co's Beginning Cash Position of ¥772.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Suzhou Novoprotein Scientific Co and its competitors. Suzhou Novoprotein Scientific Co's current Beginning Cash Position is ¥772.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Novoprotein Scientific Co stock overvalued right now?
Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co (SHSE:688137) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥39.81, compared to a current price of ¥62.15 — trading 56.1% above its estimated fair value. The current Beginning Cash Position is ¥772.6 Mil. Suzhou Novoprotein Scientific Co's overall GF Score™ is 58/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Suzhou Novoprotein Scientific Co (SHSE:688137), the current Beginning Cash Position is ¥772.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Suzhou Novoprotein Scientific Co (SHSE:688137) Overvalued in 2026?

Based on GuruFocus' analysis, Suzhou Novoprotein Scientific Co stock appears to be overvalued. The current stock price of ¥62.15 is trading 56.1% above its estimated GF Value™ of ¥39.81. GuruFocus considers Suzhou Novoprotein Scientific Co to be Significantly Overvalued.

Key valuation signals for SHSE:688137:

  • Beginning Cash Position: ¥772.6 Mil
  • GF Value™: ¥39.81 vs. price of ¥62.15 (56.1% above fair value)
  • GF Score™: 58/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688137 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Suzhou Novoprotein Scientific Co Business Description

Address No. 228, Yunchuang Road, 3rd & 4th Floor, Wujiang Economic and Technological Development Zone, Jiangsu Province, Suzhou, CHN, 215299
Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes, and reagents, Production and sales, and providing related technical services.
58GF Score

Get the complete analysis for SHSE:688137

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥62.15
Price
¥39.81
GF Value